A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Digoxin in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Isavuconazonium (Primary) ; Digoxin
- Indications Aspergillosis; Candidiasis; Zygomycosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 22 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 22 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2012 New trial record